Latest stories on AVXL
Kaplan Fox Reminds Investors of a Securities Class Action Against Anavex Life Sciences Corp. (AVXL) - Deadline is November 30, 2026
Business Insider34 · bearishgeneral
RBC cuts Aevex stock price target to $22 on contract concerns
Investing.com Analyst Ratings34 · bearishanalyst
Anavex Advances Blarcamesine Clinical Pharmacology and Rare-Disease Programs
TipRanks58 · neutralproduct/pr
ANAVEX LIFE SCIENCES CORP. (AVXL) files 8-K
SEC 8-K50 · neutralgeneral
Anavex Provides Corporate Update, Announces Completion of Clinical Conduct of ADME and DDI Clinical Studies
GlobeNewswire56 · neutralproduct/pr
Anavex Provides Corporate Update, Announces Completion of Clinical Conduct of ADME and DDI Clinical Studies
Business Insider56 · neutralproduct/pr
Anavex: Downgrading To Sell On Blarcamesine MAA Withdrawal For AD, Pipeline Change
Seeking Alpha24 · bearishanalyst
Anavex Life Sciences gains IND clearance for blarcamesine in Fragile X syndrome
Seeking Alpha74 · bullishproduct/pr
Anavex Life Sciences Gets FDA OK for Clinical Study of Genetic Disorder Treatment
MarketWatch64 · neutralproduct/pr
Anavex receives FDA clearance for Anavex2-73 IND application
The Fly74 · bullishproduct/pr